November / December 2021


The robots are coming to retina

An update of the science behind robotic-assisted vitreoretinal surgery and its potential future applications.

Two tales of DR progression

Clinical trials show encouraging outcomes for treating diabetic retinopathy progression, but the real-world evidence tells a different story.

Five things to know about biosimilars in retina

A primer on the review and approval processes as the first anti-VEGF biosimilar prepares for launch in 2022.

Mixed results in DME, PDR hemorrhage, ROP

Five abstracts on gene therapy and role of central subfield thickness in diabetic macular edema, vitreous hemorrhage and retinopathy of prematurity.


Clinical Trial Closeup

Sustained-release sunitinib comes to retina

A closer look at the extension study of GB-102 for treatment of neovascular age-related macular degeneration.

Coding Commentary

Documenting IVI: Avoiding audit traps

Documentation of intravitreal anti-VEGF injections is key as Medicare puts them under the microscope.

Editor's Page


North of the Border

10 uses for external needle drainage

This technique can be valuable in a variety of vitreoretinal surgery scenarios.

Retina Rounds

A petal-shaped blind spot

A case of acute macular neuroretinopathy developed in the context of myelofibrosis.

Social Media Specialist

Beware of social media nightmares

The pitfalls of physicians failing to maintain professional ethics online.

Surgical Pearl Video

Managing a challenging RD

Repair of a retinoschisis-associated retinal detachment in a pregnant patient.